NDC Package 51248-250-99 Vesicare LS

Solifenacin Succinate Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51248-250-99
Package Description:
1 BOTTLE, PLASTIC in 1 CARTON / 150 mL in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Vesicare LS
Non-Proprietary Name:
Solifenacin Succinate
Substance Name:
Solifenacin Succinate
Usage Information:
Solifenacin is used to treat an overactive bladder. By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics.
11-Digit NDC Billing Format:
51248025099
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2375321 - solifenacin succinate 5 MG in 5 mL Oral Suspension
  • RxCUI: 2375321 - solifenacin succinate 1 MG/ML Oral Suspension
  • RxCUI: 2375321 - solifenacin succinate 5 MG per 5 ML Oral Suspension
  • RxCUI: 2375325 - VESIcare LS 5 MG in 5 mL Oral Suspension
  • RxCUI: 2375325 - solifenacin succinate 1 MG/ML Oral Suspension [Vesicare]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Astellas Pharma Us, Inc.
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA209529
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-26-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51248-250-99?

    The NDC Packaged Code 51248-250-99 is assigned to a package of 1 bottle, plastic in 1 carton / 150 ml in 1 bottle, plastic of Vesicare LS, a human prescription drug labeled by Astellas Pharma Us, Inc.. The product's dosage form is suspension and is administered via oral form.

    Is NDC 51248-250 included in the NDC Directory?

    Yes, Vesicare LS with product code 51248-250 is active and included in the NDC Directory. The product was first marketed by Astellas Pharma Us, Inc. on May 26, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51248-250-99?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 51248-250-99?

    The 11-digit format is 51248025099. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-251248-250-995-4-251248-0250-99